NuVasive, Inc. (OQ:NUVA)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 7475 Lusk Blvd
SAN DIEGO CA 92121-5707
Tel: 1-858-4582240
Website: https://www.nuvasive.com
IR: See website
<
Key People
J. Christopher Barry
Chief Executive Officer, Director
Matthew K. Harbaugh
Executive Vice President, Chief Financial Officer
Lucas Vitale
Chief Human Resource Officer, Senior Vice President
Brent J. Boucher
Executive Vice President - Global Commercial
Massimo Calafiore
Executive Vice President - Global Business Units
Nathaniel B. Sisitsky
Senior Vice President, General Counsel, Corporate Secretary
Dale A. Wolf
Senior Vice President - Global Operations
Juliet C. Cunningham
Vice President of Investor Relations
 
Business Overview
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
Financial Overview
For the three months ended 31 March 2021, NuVasive,Inc. revenues increased 4% to $271.2M. Net loss totaled$7.5M vs. income of $5.3M. Revenues reflect Spinal Hardwaresegment increase of 7% to $204.6M, International (excludesPuerto Rico) segment increase of 13% to $63.2M, UnitedStates segment increase of 2% to $208.1M. Net loss reflectsStock-based Compensation in SGA increase from $4.2M(income) to $6M (expense).
Employees: 2,700 as of Dec 31, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $4,167M as of Mar 31, 2021
Annual revenue (TTM): $1,062M as of Mar 31, 2021
EBITDA (TTM): $183.63M as of Mar 31, 2021
Net annual income (TTM): -$49.96M as of Mar 31, 2021
Free cash flow (TTM): $107.07M as of Mar 31, 2021
Net Debt Last Fiscal Year: $647.08M as of Mar 31, 2021
Shares outstanding: 51,648,864 as of May 3, 2021
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.